Kiniksa Pharmaceuticals International, plc
KNSA stock score: 65/100
$80.79 · +1.37% · Scored Oct 22, 2026
- Technical
- 69
- Fundamental
- 61
- News
- 51
The reading
Kiniksa Pharmaceuticals International (KNSA) scores 65 out of 100, which reads neutral, higher than 94% of Healthcare stocks and 89% of the 4,161 US stocks we score.
The composite is technicals and fundamentals weighted equally: technicals read 69, fundamentals 61.
Among the fundamentals, Price Target at 100 and Earnings Growth (Annual) at 100 score highest, while EV/EBITDA at 1 weighs the most against it.
On the daily chart, trend-following indicators average 63 and contrarian oscillators 30 — a split worth reading before trusting the technical total.
News sentiment is neutral at 51; it is shown, not counted in the composite.
Since Jul 25, 2026 the composite has ranged from 61 to 79, and it is down 13 points over the period.
What’s driving the score
The strongest and weakest of the scorers that count toward KNSA’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.
Fundamental
61Pulling it up
- Price Target100
Price target score compares the current stock price to analyst consensus targets.
- Earnings Growth (Annual)100
Annual earnings growth tracks year-over-year profit expansion.
- Revenue Quality (Quarterly)100
Revenue Quality (Quarterly) evaluates recent revenue performance using trailing 12-month data from quarterly reports.
Holding it back
- EV/EBITDA1
EV/EBITDA compares the whole company's value, debt included, with its operating earnings before depreciation.
- Trailing P/E1
Trailing P/E ratio uses the last 12 months of actual earnings.
- Price to Book Ratio2
Price-to-Book ratio compares market value to book value.
39 weighted scorers; 2 had no data today and are left out rather than counted as zero.
Technical · daily
61Pulling it up
- Parabolic SAR (PSAR)100
Parabolic SAR (Stop and Reverse) provides trailing stop levels that follow price trends.
- EMA 200100
Exponential Moving Average (200-period) is a crucial long-term trend indicator that reacts faster than SMA-200.
- SMA 200100
Simple Moving Average (200-period) is the most widely followed long-term trend indicator.
Holding it back
- TRIX11
TRIX is a momentum oscillator that filters out short-term noise by triple-smoothing price data.
- Bollinger Bands (50)13
Bollinger Bands (50-period) measure where price sits between bands two standard deviations around its 50-period average.
- Bollinger Bands (20)18
Bollinger Bands (20-period) plot standard deviations above and below a moving average.
61 weighted scorers; 4 had no data today and are left out rather than counted as zero.
News · shown, not counted
- Global News
- 51
Technical score by timeframe
| Chart | Score | Weight |
|---|---|---|
| Hourly | 50 | 1 |
| Daily | 61 | 3 |
| Weekly | 72 | 2 |
| Monthly | 76 | 2 |
| Quarterly | 81 | 2 |
Composite score, last 90 days
Show the daily numbers
| Date | Composite |
|---|---|
| Oct 22, 2026 | 65 |
| Oct 21, 2026 | 65 |
| Oct 20, 2026 | 67 |
| Oct 19, 2026 | 65 |
| Oct 18, 2026 | 64 |
| Oct 17, 2026 | 64 |
| Oct 16, 2026 | 64 |
| Oct 15, 2026 | 66 |
| Oct 14, 2026 | 65 |
| Oct 13, 2026 | 65 |
| Oct 12, 2026 | 66 |
| Oct 11, 2026 | 66 |
| Oct 10, 2026 | 66 |
| Oct 9, 2026 | 66 |
| Oct 8, 2026 | 66 |
| Oct 7, 2026 | 65 |
| Oct 6, 2026 | 65 |
| Oct 5, 2026 | 63 |
| Oct 4, 2026 | 64 |
| Oct 3, 2026 | 64 |
| Oct 2, 2026 | 64 |
| Oct 1, 2026 | 62 |
| Sep 30, 2026 | 62 |
| Sep 29, 2026 | 63 |
| Sep 28, 2026 | 63 |
| Sep 27, 2026 | 62 |
| Sep 26, 2026 | 62 |
| Sep 25, 2026 | 62 |
| Sep 24, 2026 | 64 |
| Sep 23, 2026 | 65 |
| Sep 22, 2026 | 66 |
| Sep 21, 2026 | 65 |
| Sep 20, 2026 | 64 |
| Sep 19, 2026 | 64 |
| Sep 18, 2026 | 64 |
| Sep 17, 2026 | 66 |
| Sep 16, 2026 | 64 |
| Sep 15, 2026 | 62 |
| Sep 14, 2026 | 64 |
| Sep 13, 2026 | 63 |
| Sep 12, 2026 | 63 |
| Sep 11, 2026 | 63 |
| Sep 10, 2026 | 63 |
| Sep 9, 2026 | 66 |
| Sep 8, 2026 | 66 |
| Sep 7, 2026 | 64 |
| Sep 6, 2026 | 64 |
| Sep 5, 2026 | 64 |
| Sep 4, 2026 | 66 |
| Sep 3, 2026 | 68 |
| Sep 2, 2026 | 67 |
| Sep 1, 2026 | 67 |
| Aug 31, 2026 | 65 |
| Aug 30, 2026 | 66 |
| Aug 29, 2026 | 66 |
| Aug 28, 2026 | 64 |
| Aug 27, 2026 | 66 |
| Aug 26, 2026 | 65 |
| Aug 25, 2026 | 67 |
| Aug 24, 2026 | 67 |
| Aug 23, 2026 | 67 |
| Aug 22, 2026 | 67 |
| Aug 20, 2026 | 67 |
| Aug 19, 2026 | 68 |
| Aug 18, 2026 | 68 |
| Aug 17, 2026 | 68 |
| Aug 16, 2026 | 67 |
| Aug 15, 2026 | 67 |
| Aug 14, 2026 | 67 |
| Aug 13, 2026 | 67 |
| Aug 12, 2026 | 68 |
| Aug 11, 2026 | 68 |
| Aug 10, 2026 | 68 |
| Aug 9, 2026 | 67 |
| Aug 8, 2026 | 67 |
| Aug 7, 2026 | 66 |
| Aug 6, 2026 | 62 |
| Aug 5, 2026 | 62 |
| Aug 3, 2026 | 61 |
| Aug 2, 2026 | 62 |
| Jul 31, 2026 | 76 |
| Jul 30, 2026 | 79 |
| Jul 29, 2026 | 78 |
| Jul 28, 2026 | 77 |
| Jul 27, 2026 | 76 |
| Jul 26, 2026 | 78 |
| Jul 25, 2026 | 78 |
Key facts
- Market cap
- $6.3B
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Beta
- 0.04
- Risk grade (1–10)
- 9
- Next earnings
- Oct 27, 2026
Drug Manufacturers - Specialty & Generic peers
| Company | Market cap | Score |
|---|---|---|
| ALKS Alkermes | $7.4B | 58 |
| AMRX Amneal Pharmaceuticals | $7.1B | 65 |
| HIMS Hims & Hers Health | $6.8B | 51 |
| LNTH Lantheus | $6.5B | 65 |
| RGC Regencell Bioscience Holdings | $4.9B | 36 |
| INDV Indivior Pharmaceuticals | $4.2B | 66 |
Questions
What is KNSA's stock score today?
KNSA scores 65/100 (Neutral) as of Oct 22, 2026: technical 69, fundamental 61, and news sentiment 51, which is shown but not counted. Scores are recomputed every night.
Is KNSA a buy?
The score is not a buy or sell recommendation. A 65 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.
How is the KNSA score calculated?
100 weighted scorers feed it today: 39 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.
Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.